NEO
insider transactionsNEOGENOMICS INC — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-10.6K
0 buy · 10.6K sell
Net value · 90d
-$118.8K
$0 in · $118.8K out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
2
0 buy · 10.6K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Director · 10b5-1
$58.9K
5.3K sh · $11.10
Own -6%
-
Sell·S
Director · 10b5-1
$59.9K
5.3K sh · $11.29
Own -5%
-
Grant·A
Director
$0
75.0K sh
Own New
-
Grant·A
Director
$0
46.1K sh
Own +28%
-
Grant·A
Director
$0
16.0K sh
Own New
-
Grant·A
Director
$0
11.1K sh
Own New
-
Exercise·M
Director
$0
23.1K sh
Own New
-
Exercise·M
Director
$0
23.1K sh
Own +322%
-
Grant·A
Director
$0
16.0K sh
Own New
-
Grant·A
Director
$0
11.1K sh
Own New
-
Exercise·M
Director
$0
23.1K sh
Own New
-
Exercise·M
Director
$0
23.1K sh
Own +31%
-
Grant·A
Director
$0
16.0K sh
Own New
-
Grant·A
Director
$0
11.1K sh
Own New
-
Exercise·M
Director
$0
23.1K sh
Own New
-
Exercise·M
Director
$0
23.1K sh
Own +68%
-
Grant·A
Director
$0
16.0K sh
Own New
-
Grant·A
Director
$0
11.1K sh
Own New
-
Exercise·M
Director
$0
5.9K sh
Own New
-
Exercise·M
Director
$0
5.9K sh
Own New
-
Grant·A
Director
$0
16.0K sh
Own New
-
Grant·A
Director
$0
11.1K sh
Own New
-
Exercise·M
Director
$0
23.1K sh
Own New
-
Exercise·M
Director
$0
23.1K sh
Own +52%
-
Grant·A
Director
$0
16.0K sh
Own New
-
Grant·A
Director
$0
11.1K sh
Own New
-
Exercise·M
Director
$0
23.1K sh
Own New
-
Exercise·M
Director
$0
23.1K sh
Own +44%
-
Grant·A
Director
$0
16.0K sh
Own New
-
Grant·A
Director
$0
11.1K sh
Own New
-
Exercise·M
Director
$0
23.1K sh
Own New
-
Exercise·M
Director
$0
23.1K sh
Own +82%
-
Grant·A
Director
$0
16.0K sh
Own New
-
Grant·A
Director
$0
11.1K sh
Own New
-
Exercise·M
Director
$0
23.0K sh
Own New
-
Exercise·M
Director
$0
23.0K sh
Own New
-
Grant·A
Director
$0
251.2K sh
Own New
-
Exercise·M
EVP, GC & Business Development
$0
3.9K sh
Own New
-
Other·F
EVP, GC & Business Development
$0
2.6K sh
Own -3%
-
Exercise·M
EVP, GC & Business Development
$0
3.9K sh
Own +4%
-
Exercise·M
Pres & Chief Operating Officer
$0
5.8K sh
Own New
-
Other·F
Pres & Chief Operating Officer
$0
3.8K sh
Own -2%
-
Exercise·M
Pres & Chief Operating Officer
$0
5.8K sh
Own +4%
-
Exercise·M
Pres & Chief Operating Officer
$0
6.0K sh
Own +100%
-
Other·F
Pres & Chief Operating Officer
$0
2.3K sh
Own -1%
-
Exercise·M
Pres & Chief Operating Officer
$0
6.0K sh
Own +4%
-
Exercise·M
Chief Accounting Officer
$0
5.4K sh
Own +100%
-
Other·F
Chief Accounting Officer
$0
1.3K sh
Own -5%
-
Exercise·M
Chief Accounting Officer
$0
5.4K sh
Own +25%
-
Other·F
EVP, GC & Business Development
$0
1.0K sh
Own -1%
-
Other·F
Chief Accounting Officer
$0
937 sh
Own -4%
-
Exercise·M
Pres & Chief Operating Officer
$0
17.6K sh
Own +100%
-
Other·F
Pres & Chief Operating Officer
$0
6.9K sh
Own -4%
-
Exercise·M
Pres & Chief Operating Officer
$0
17.6K sh
Own +12%
-
Exercise·M
Anthony P. Zook KEY
Chief Executive Officer
$0
140.5K sh
Own +100%
-
Other·F
Anthony P. Zook KEY
Chief Executive Officer
$0
45.5K sh
Own -25%
-
Exercise·M
Anthony P. Zook KEY
Chief Executive Officer
$0
140.5K sh
Own +369%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Lynn A. Tetrault 10b5-1 | Sell S | 5.3K | $58.9K |
| Jun 9, 2026 | Lynn A. Tetrault 10b5-1 | Sell S | 5.3K | $59.9K |
| Jun 5, 2026 | Michael Aaron Kelly | Grant A | 75.0K | $0 |
| Jun 3, 2026 | John P. Kenny | Grant A | 46.1K | $0 |
| Jun 1, 2026 | Felicia Williams | Grant A | 16.0K | $0 |
| Jun 1, 2026 | Felicia Williams | Grant A | 11.1K | $0 |
| Jun 1, 2026 | Felicia Williams | Exercise M | 23.1K | $0 |
| Jun 1, 2026 | Felicia Williams | Exercise M | 23.1K | $0 |
| Jun 1, 2026 | Lynn A. Tetrault | Grant A | 16.0K | $0 |
| Jun 1, 2026 | Lynn A. Tetrault | Grant A | 11.1K | $0 |
| Jun 1, 2026 | Lynn A. Tetrault | Exercise M | 23.1K | $0 |
| Jun 1, 2026 | Lynn A. Tetrault | Exercise M | 23.1K | $0 |
| Jun 1, 2026 | David Brian Perez | Grant A | 16.0K | $0 |
| Jun 1, 2026 | David Brian Perez | Grant A | 11.1K | $0 |
| Jun 1, 2026 | David Brian Perez | Exercise M | 23.1K | $0 |
| Jun 1, 2026 | David Brian Perez | Exercise M | 23.1K | $0 |
| Jun 1, 2026 | John P. Kenny | Grant A | 16.0K | $0 |
| Jun 1, 2026 | John P. Kenny | Grant A | 11.1K | $0 |
| Jun 1, 2026 | John P. Kenny | Exercise M | 5.9K | $0 |
| Jun 1, 2026 | John P. Kenny | Exercise M | 5.9K | $0 |
| Jun 1, 2026 | Michael Aaron Kelly | Grant A | 16.0K | $0 |
| Jun 1, 2026 | Michael Aaron Kelly | Grant A | 11.1K | $0 |
| Jun 1, 2026 | Michael Aaron Kelly | Exercise M | 23.1K | $0 |
| Jun 1, 2026 | Michael Aaron Kelly | Exercise M | 23.1K | $0 |
| Jun 1, 2026 | Stephen M Kanovsky | Grant A | 16.0K | $0 |
| Jun 1, 2026 | Stephen M Kanovsky | Grant A | 11.1K | $0 |
| Jun 1, 2026 | Stephen M Kanovsky | Exercise M | 23.1K | $0 |
| Jun 1, 2026 | Stephen M Kanovsky | Exercise M | 23.1K | $0 |
| Jun 1, 2026 | Neil Gunn | Grant A | 16.0K | $0 |
| Jun 1, 2026 | Neil Gunn | Grant A | 11.1K | $0 |
| Jun 1, 2026 | Neil Gunn | Exercise M | 23.1K | $0 |
| Jun 1, 2026 | Neil Gunn | Exercise M | 23.1K | $0 |
| Jun 1, 2026 | Marjorie C Green | Grant A | 16.0K | $0 |
| Jun 1, 2026 | Marjorie C Green | Grant A | 11.1K | $0 |
| Jun 1, 2026 | Marjorie C Green | Exercise M | 23.0K | $0 |
| Jun 1, 2026 | Marjorie C Green | Exercise M | 23.0K | $0 |
| May 18, 2026 | John P. Kenny | Grant A | 251.2K | $0 |
| May 11, 2026 | Alicia C Olivo | Exercise M | 3.9K | $0 |
| May 11, 2026 | Alicia C Olivo | Other F | 2.6K | $0 |
| May 11, 2026 | Alicia C Olivo | Exercise M | 3.9K | $0 |
| May 11, 2026 | Warren Stone | Exercise M | 5.8K | $0 |
| May 11, 2026 | Warren Stone | Other F | 3.8K | $0 |
| May 11, 2026 | Warren Stone | Exercise M | 5.8K | $0 |
| May 2, 2026 | Warren Stone | Exercise M | 6.0K | $0 |
| May 2, 2026 | Warren Stone | Other F | 2.3K | $0 |
| May 2, 2026 | Warren Stone | Exercise M | 6.0K | $0 |
| May 2, 2026 | Greg D Aunan | Exercise M | 5.4K | $0 |
| May 2, 2026 | Greg D Aunan | Other F | 1.3K | $0 |
| May 2, 2026 | Greg D Aunan | Exercise M | 5.4K | $0 |
| May 1, 2026 | Alicia C Olivo | Other F | 1.0K | $0 |
| May 1, 2026 | Greg D Aunan | Other F | 937 | $0 |
| Apr 1, 2026 | Warren Stone | Exercise M | 17.6K | $0 |
| Apr 1, 2026 | Warren Stone | Other F | 6.9K | $0 |
| Apr 1, 2026 | Warren Stone | Exercise M | 17.6K | $0 |
| Apr 1, 2026 | Anthony P. Zook KEY | Exercise M | 140.5K | $0 |
| Apr 1, 2026 | Anthony P. Zook KEY | Other F | 45.5K | $0 |
| Apr 1, 2026 | Anthony P. Zook KEY | Exercise M | 140.5K | $0 |
About NEO insider trading
This page tracks insider transactions for NEOGENOMICS INC (NEO) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.